Product Liability Reform: HB 1 (1987).
Provides that a product’s design is not defective if: (1)
Provides that a product’s design is not defective if: (1) an injury occurs due to the inherent characteristics of a product, where the characteristics are recognized by the ordinary person with ordinary knowledge common to the community; or (2) an injury occurs because of a design which is state of the art, unless the manufacturer acted unreasonably in introducing the product into trade or commerce. Provides that a product is not defective due to lack of warnings if the risk is open and obvious or is a risk that is a matter of common knowledge. Establishes a complete defense for manufacturers and sellers of ethical drugs and/or devices if they have supplied adequate warnings to learned intermediaries, unless the FDA requires additional warnings. Provides that a drug manufacturer shall not be liable for punitive damages if the drug was approved by the FDA.
Latest News
View all news
Groups Urge Congressional Scrutiny of D.C. Attorney General’s Use of Private Attorneys
Concerns Mount Over Outside Counsel Contracts and Litigation Agendas
America’s $367 Billion Lawsuit Epidemic
The Hidden Tax Crushing Families and Businesses
$745 Million Verdict in Coastal Litigation Exemplifies Louisiana’s ‘Judicial Hellhole®’ Status
Excessive Litigation Costs Residents $1,011 Annually and Jeopardizes 40,000 Jobs Each Year
Alarming Expansion in Public Nuisance Litigation Revealed by ATRA Report
From Social Media to Car Thefts, New Litigation Trends Threaten Entire Industries
Georgia Legislature Passes Landmark Tort Reform Bill
ATRA Applauds Passage, Anticipates Governor’s Signature on SB 68
The trial lawyer playbook: How aggressive advertising and junk science are costing Californians
In 2024, legal services ads hit $164 million in LA, part of a 39% national rise, fueling aggressive marketing, third-party funding, and straining California’s economy and courts.